Biomimetic Nanocarriers for Cancer Target Therapy

Nanotechnology offers innovative tools for the design of biomimetic nanocarriers for targeted cancer therapy. These nano-systems present several advantages such as cargo's protection and modulation of its release, inclusion of stimuli-responsive elements, and enhanced tumoral accumulation. All...

Full description

Saved in:
Bibliographic Details
Published in:Bioengineering (Basel) 2020-09, Vol.7 (3), p.111
Main Authors: Guido, Clara, Maiorano, Gabriele, Cortese, Barbara, D'Amone, Stefania, Palamà, Ilaria Elena
Format: Article
Language:English
Subjects:
Biocompatibility
Bioengineering
Biomedical materials
biomimetic nanoparticles
Biomimetics
Blood platelets
Cancer
Cancer therapies
cancer therapy
Cell membranes
Chemotherapy
Clinical trials
Erythrocytes
Immune clearance
Immune system
immunotherapy
Leukocytes
Membranes
Metastasis
Nanomaterials
Nanoparticles
Nanotechnology
Platelets
Polymers
Proteins
Review
Stem cells
Therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c571t-cf5b34ed1344b6bd463f6c89974e95d8f136f9e54613e698a393f84f2293fbbf3
cites cdi_FETCH-LOGICAL-c571t-cf5b34ed1344b6bd463f6c89974e95d8f136f9e54613e698a393f84f2293fbbf3
container_end_page
container_issue 3
container_start_page 111
container_title Bioengineering (Basel)
container_volume 7
creator Guido, Clara
Maiorano, Gabriele
Cortese, Barbara
D'Amone, Stefania
Palamà, Ilaria Elena
description Nanotechnology offers innovative tools for the design of biomimetic nanocarriers for targeted cancer therapy. These nano-systems present several advantages such as cargo's protection and modulation of its release, inclusion of stimuli-responsive elements, and enhanced tumoral accumulation. All together, these nano-systems suffer low therapeutic efficacy in vivo because organisms can recognize and remove foreign nanomaterials. To overcome this important issue, different modifications on nanoparticle surfaces were exploited in order to reach the desired therapeutic efficacy eliciting, also, the response of immune system against cancer cells. For this reason, more recently, a new strategy involving cell membrane-covered nanoparticles for biomedical application has been attracting increasing attention. Membranes from red blood cells, platelets, leukocytes, tumor, and stem cells, have been exploited as biomimetic coatings of nanoparticles for evading clearance or stimulated immune system by maintaining in the same way their targeting capability. In this review, the use of different cell sources as coating of biomimetic nanocarriers for cancer therapy is discussed.
doi_str_mv 10.3390/bioengineering7030111
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_8c100422b3f642a1a0f069c86a19fb80</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_8c100422b3f642a1a0f069c86a19fb80</doaj_id><sourcerecordid>2443881848</sourcerecordid><originalsourceid>FETCH-LOGICAL-c571t-cf5b34ed1344b6bd463f6c89974e95d8f136f9e54613e698a393f84f2293fbbf3</originalsourceid><addsrcrecordid>eNptkVFrHCEUhaU0NCHJT2gZ6EtfNlWvOvpSaJe2CYTmZfssjnOduMzo1pkN5N_XZtOQlIKg6LnfPd5DyFtGLwAM_djFjGmICbHENLQUKGPsFTnhQNVKghSvn52Pyfk8bymlDLjkSrwhx8ANtEbBCWFfYp7ihEv0zQ-XsnelRCxzE3Jp1i55LM3GlQGXZnOLxe3uz8hRcOOM54_7Kfn57etmfbm6vvl-tf58vfKyZcvKB9mBwJ6BEJ3qeqEgKK-NaQUa2evAQAWDUigGqIx2YCBoEXi1FrouwCm5OnD77LZ2V-Lkyr3NLtqHi1wG60q1PaLVnlEqOO9qC8EdczRQZbxWjpnQaVpZnw6s3b6bsPeYluLGF9CXLyne2iHf2VZK3mqogA-PgJJ_7XFe7BRnj-PoEub9bLkQoDXTQlfp-3-k27wvqY7K1vGLuqjhVSUPKl_yPBcMT2YYtX8ytv_NuNa9e_6Tp6q_icJv_9elBg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2524524092</pqid></control><display><type>article</type><title>Biomimetic Nanocarriers for Cancer Target Therapy</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Guido, Clara ; Maiorano, Gabriele ; Cortese, Barbara ; D'Amone, Stefania ; Palamà, Ilaria Elena</creator><creatorcontrib>Guido, Clara ; Maiorano, Gabriele ; Cortese, Barbara ; D'Amone, Stefania ; Palamà, Ilaria Elena</creatorcontrib><description>Nanotechnology offers innovative tools for the design of biomimetic nanocarriers for targeted cancer therapy. These nano-systems present several advantages such as cargo's protection and modulation of its release, inclusion of stimuli-responsive elements, and enhanced tumoral accumulation. All together, these nano-systems suffer low therapeutic efficacy in vivo because organisms can recognize and remove foreign nanomaterials. To overcome this important issue, different modifications on nanoparticle surfaces were exploited in order to reach the desired therapeutic efficacy eliciting, also, the response of immune system against cancer cells. For this reason, more recently, a new strategy involving cell membrane-covered nanoparticles for biomedical application has been attracting increasing attention. Membranes from red blood cells, platelets, leukocytes, tumor, and stem cells, have been exploited as biomimetic coatings of nanoparticles for evading clearance or stimulated immune system by maintaining in the same way their targeting capability. In this review, the use of different cell sources as coating of biomimetic nanocarriers for cancer therapy is discussed.</description><identifier>ISSN: 2306-5354</identifier><identifier>EISSN: 2306-5354</identifier><identifier>DOI: 10.3390/bioengineering7030111</identifier><identifier>PMID: 32937963</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Biocompatibility ; Bioengineering ; Biomedical materials ; biomimetic nanoparticles ; Biomimetics ; Blood platelets ; Cancer ; Cancer therapies ; cancer therapy ; Cell membranes ; Chemotherapy ; Clinical trials ; Erythrocytes ; Immune clearance ; Immune system ; immunotherapy ; Leukocytes ; Membranes ; Metastasis ; Nanomaterials ; Nanoparticles ; Nanotechnology ; Platelets ; Polymers ; Proteins ; Review ; Stem cells ; Therapy</subject><ispartof>Bioengineering (Basel), 2020-09, Vol.7 (3), p.111</ispartof><rights>2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c571t-cf5b34ed1344b6bd463f6c89974e95d8f136f9e54613e698a393f84f2293fbbf3</citedby><cites>FETCH-LOGICAL-c571t-cf5b34ed1344b6bd463f6c89974e95d8f136f9e54613e698a393f84f2293fbbf3</cites><orcidid>0000-0001-8667-7255 ; 0000-0003-2205-2293 ; 0000-0003-4420-0680</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2524524092/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2524524092?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32937963$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Guido, Clara</creatorcontrib><creatorcontrib>Maiorano, Gabriele</creatorcontrib><creatorcontrib>Cortese, Barbara</creatorcontrib><creatorcontrib>D'Amone, Stefania</creatorcontrib><creatorcontrib>Palamà, Ilaria Elena</creatorcontrib><title>Biomimetic Nanocarriers for Cancer Target Therapy</title><title>Bioengineering (Basel)</title><addtitle>Bioengineering (Basel)</addtitle><description>Nanotechnology offers innovative tools for the design of biomimetic nanocarriers for targeted cancer therapy. These nano-systems present several advantages such as cargo's protection and modulation of its release, inclusion of stimuli-responsive elements, and enhanced tumoral accumulation. All together, these nano-systems suffer low therapeutic efficacy in vivo because organisms can recognize and remove foreign nanomaterials. To overcome this important issue, different modifications on nanoparticle surfaces were exploited in order to reach the desired therapeutic efficacy eliciting, also, the response of immune system against cancer cells. For this reason, more recently, a new strategy involving cell membrane-covered nanoparticles for biomedical application has been attracting increasing attention. Membranes from red blood cells, platelets, leukocytes, tumor, and stem cells, have been exploited as biomimetic coatings of nanoparticles for evading clearance or stimulated immune system by maintaining in the same way their targeting capability. In this review, the use of different cell sources as coating of biomimetic nanocarriers for cancer therapy is discussed.</description><subject>Biocompatibility</subject><subject>Bioengineering</subject><subject>Biomedical materials</subject><subject>biomimetic nanoparticles</subject><subject>Biomimetics</subject><subject>Blood platelets</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>cancer therapy</subject><subject>Cell membranes</subject><subject>Chemotherapy</subject><subject>Clinical trials</subject><subject>Erythrocytes</subject><subject>Immune clearance</subject><subject>Immune system</subject><subject>immunotherapy</subject><subject>Leukocytes</subject><subject>Membranes</subject><subject>Metastasis</subject><subject>Nanomaterials</subject><subject>Nanoparticles</subject><subject>Nanotechnology</subject><subject>Platelets</subject><subject>Polymers</subject><subject>Proteins</subject><subject>Review</subject><subject>Stem cells</subject><subject>Therapy</subject><issn>2306-5354</issn><issn>2306-5354</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkVFrHCEUhaU0NCHJT2gZ6EtfNlWvOvpSaJe2CYTmZfssjnOduMzo1pkN5N_XZtOQlIKg6LnfPd5DyFtGLwAM_djFjGmICbHENLQUKGPsFTnhQNVKghSvn52Pyfk8bymlDLjkSrwhx8ANtEbBCWFfYp7ihEv0zQ-XsnelRCxzE3Jp1i55LM3GlQGXZnOLxe3uz8hRcOOM54_7Kfn57etmfbm6vvl-tf58vfKyZcvKB9mBwJ6BEJ3qeqEgKK-NaQUa2evAQAWDUigGqIx2YCBoEXi1FrouwCm5OnD77LZ2V-Lkyr3NLtqHi1wG60q1PaLVnlEqOO9qC8EdczRQZbxWjpnQaVpZnw6s3b6bsPeYluLGF9CXLyne2iHf2VZK3mqogA-PgJJ_7XFe7BRnj-PoEub9bLkQoDXTQlfp-3-k27wvqY7K1vGLuqjhVSUPKl_yPBcMT2YYtX8ytv_NuNa9e_6Tp6q_icJv_9elBg</recordid><startdate>20200914</startdate><enddate>20200914</enddate><creator>Guido, Clara</creator><creator>Maiorano, Gabriele</creator><creator>Cortese, Barbara</creator><creator>D'Amone, Stefania</creator><creator>Palamà, Ilaria Elena</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>L6V</scope><scope>LK8</scope><scope>M7P</scope><scope>M7S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8667-7255</orcidid><orcidid>https://orcid.org/0000-0003-2205-2293</orcidid><orcidid>https://orcid.org/0000-0003-4420-0680</orcidid></search><sort><creationdate>20200914</creationdate><title>Biomimetic Nanocarriers for Cancer Target Therapy</title><author>Guido, Clara ; Maiorano, Gabriele ; Cortese, Barbara ; D'Amone, Stefania ; Palamà, Ilaria Elena</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c571t-cf5b34ed1344b6bd463f6c89974e95d8f136f9e54613e698a393f84f2293fbbf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Biocompatibility</topic><topic>Bioengineering</topic><topic>Biomedical materials</topic><topic>biomimetic nanoparticles</topic><topic>Biomimetics</topic><topic>Blood platelets</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>cancer therapy</topic><topic>Cell membranes</topic><topic>Chemotherapy</topic><topic>Clinical trials</topic><topic>Erythrocytes</topic><topic>Immune clearance</topic><topic>Immune system</topic><topic>immunotherapy</topic><topic>Leukocytes</topic><topic>Membranes</topic><topic>Metastasis</topic><topic>Nanomaterials</topic><topic>Nanoparticles</topic><topic>Nanotechnology</topic><topic>Platelets</topic><topic>Polymers</topic><topic>Proteins</topic><topic>Review</topic><topic>Stem cells</topic><topic>Therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guido, Clara</creatorcontrib><creatorcontrib>Maiorano, Gabriele</creatorcontrib><creatorcontrib>Cortese, Barbara</creatorcontrib><creatorcontrib>D'Amone, Stefania</creatorcontrib><creatorcontrib>Palamà, Ilaria Elena</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Bioengineering (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guido, Clara</au><au>Maiorano, Gabriele</au><au>Cortese, Barbara</au><au>D'Amone, Stefania</au><au>Palamà, Ilaria Elena</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biomimetic Nanocarriers for Cancer Target Therapy</atitle><jtitle>Bioengineering (Basel)</jtitle><addtitle>Bioengineering (Basel)</addtitle><date>2020-09-14</date><risdate>2020</risdate><volume>7</volume><issue>3</issue><spage>111</spage><pages>111-</pages><issn>2306-5354</issn><eissn>2306-5354</eissn><abstract>Nanotechnology offers innovative tools for the design of biomimetic nanocarriers for targeted cancer therapy. These nano-systems present several advantages such as cargo's protection and modulation of its release, inclusion of stimuli-responsive elements, and enhanced tumoral accumulation. All together, these nano-systems suffer low therapeutic efficacy in vivo because organisms can recognize and remove foreign nanomaterials. To overcome this important issue, different modifications on nanoparticle surfaces were exploited in order to reach the desired therapeutic efficacy eliciting, also, the response of immune system against cancer cells. For this reason, more recently, a new strategy involving cell membrane-covered nanoparticles for biomedical application has been attracting increasing attention. Membranes from red blood cells, platelets, leukocytes, tumor, and stem cells, have been exploited as biomimetic coatings of nanoparticles for evading clearance or stimulated immune system by maintaining in the same way their targeting capability. In this review, the use of different cell sources as coating of biomimetic nanocarriers for cancer therapy is discussed.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>32937963</pmid><doi>10.3390/bioengineering7030111</doi><orcidid>https://orcid.org/0000-0001-8667-7255</orcidid><orcidid>https://orcid.org/0000-0003-2205-2293</orcidid><orcidid>https://orcid.org/0000-0003-4420-0680</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2306-5354
ispartof Bioengineering (Basel), 2020-09, Vol.7 (3), p.111
issn 2306-5354
2306-5354
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_8c100422b3f642a1a0f069c86a19fb80
source Publicly Available Content Database; PubMed Central
subjects Biocompatibility
Bioengineering
Biomedical materials
biomimetic nanoparticles
Biomimetics
Blood platelets
Cancer
Cancer therapies
cancer therapy
Cell membranes
Chemotherapy
Clinical trials
Erythrocytes
Immune clearance
Immune system
immunotherapy
Leukocytes
Membranes
Metastasis
Nanomaterials
Nanoparticles
Nanotechnology
Platelets
Polymers
Proteins
Review
Stem cells
Therapy
title Biomimetic Nanocarriers for Cancer Target Therapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T06%3A07%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biomimetic%20Nanocarriers%20for%20Cancer%20Target%20Therapy&rft.jtitle=Bioengineering%20(Basel)&rft.au=Guido,%20Clara&rft.date=2020-09-14&rft.volume=7&rft.issue=3&rft.spage=111&rft.pages=111-&rft.issn=2306-5354&rft.eissn=2306-5354&rft_id=info:doi/10.3390/bioengineering7030111&rft_dat=%3Cproquest_doaj_%3E2443881848%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c571t-cf5b34ed1344b6bd463f6c89974e95d8f136f9e54613e698a393f84f2293fbbf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2524524092&rft_id=info:pmid/32937963&rfr_iscdi=true